You just read:

DelMar Pharmaceuticals Initiates Phase 2 Clinical Trial in Newly Diagnosed MGMT-unmethylated Glioblastoma Multiforme

News provided by

DelMar Pharmaceuticals, Inc.

Sep 11, 2017, 04:00 ET